As we rapidly approach the fifth month of the year, the Center for Medicare and Medicaid Services (CMS) has yet to issue its much-awaited “fresh look” guidance on shared space arrangements between hospitals and other entities, such as physician practices and ambulatory surgery centers. David Wright, deputy director of CMS’s Center for Clinical Standards and Quality, talked about CMS’s new direction at the American Health Lawyers Association (AHLA) conference in March 2018 and again during an AHLA webinar in November, indicating that the guidance was in the final stages of development and could be released any day. But so far, nothing. Read More ›
Fifty years ago, auto manufacturing plants were filled with thousands of people on large assembly lines. Flash forward to today and these same plants are filled with robots working alongside individuals, and in some cases, entirely replacing human workers. Read More ›
On April 25, 2019, the West Virginia Treasurer’s Office issued a request for proposals (RFP) seeking bids from financial institutions to provide banking services to West Virginia’s medical cannabis program. Read More ›
The 2018 Farm Bill’s legalization of hemp set the stage for a resurgence in hemp production and the proliferation of hemp-derived cannabidiol (CBD) products. What’s more, numerous states have introduced or passed bills legalizing medical marijuana, despite marijuana’s classification as a Schedule 1 substance under federal law. Read More ›
State laws vary considerably in terms of the professional obligations they place on physicians obtaining a patient’s informed consent for the use of medical marijuana. Ohio, for example, requires a physician to document in the medical record the patient’s consent (or legal representative’s consent if the patient is a minor) to medical marijuana treatment prior to completing a recommendation. Ohio Administrative Code 4731-32-03. Read More ›
As a result of huge costs and pricing pressures, many drug development players are now participating in public-private partnerships (PPP) to share the costs of drug development efforts. Read More ›
Ask the Blogger
Do you have a topic that you would like discussed in a future blog article? Please let us know. If you have a confidential question regarding a blog article, please feel free to contact the article's author directly, or let us know if you would like for someone to contact you directly.
James (Jim) A. Dietz is a Member at FBT who provides an array of legal services to hospitals, physicians, long-term care providers, diagnostic facilities, and others across the spectrum of patient care.